发明授权
- 专利标题： MANF2 for treatment of Parkinson's disease
- 专利标题（中）： MANF2用于治疗帕金森病
-
申请号： US12037535申请日： 2008-02-26
-
公开(公告)号： US09127082B2公开(公告)日： 2015-09-08
- 发明人: Mart Saarma , Juha Lauren , Paivi Lindholm , Tonis Timmusk , Raimo Tuominen
- 申请人： Mart Saarma , Juha Lauren , Paivi Lindholm , Tonis Timmusk , Raimo Tuominen
- 申请人地址： FI Helsinki
- 专利权人： HERANTIS PHARMA PLC.
- 当前专利权人： HERANTIS PHARMA PLC.
- 当前专利权人地址： FI Helsinki
- 代理机构： Birch, Stewart, Kolasch & Birch, LLP
- 主分类号： A61K48/00
- IPC分类号： A61K48/00 ; A61P25/16 ; C12N15/86 ; C07K14/475 ; A61K38/00
摘要：
The present invention discloses a novel neurotrophic factor protein, MANF2 and a genetic sequence encoding the same. The molecule will be useful in the development of a range of therapeutics and diagnostics useful in the treatment, prophylaxis and/or diagnosis of MANF2 dependent conditions. The molecule of the present invention is also a useful effector of primary and central neurons, especially dopaminergic neurons at the central nervous system and growth factor genes.
公开/授权文献
- US20080269154A1 Novel neurotrophic factor protein and uses thereof 公开/授权日：2008-10-30
信息查询
